Jefferies Group LLC reiterated their buy rating on shares of Medical Properties Trust, Inc. (NYSE:MPW) in a research note published on Tuesday. The brokerage currently has a $15.00 target price on the real estate investment trust’s stock.

A number of other research analysts have also issued reports on the company. Zacks Investment Research raised Medical Properties Trust from a hold rating to a buy rating and set a $15.00 target price on the stock in a report on Wednesday, July 19th. BidaskClub lowered Medical Properties Trust from a hold rating to a sell rating in a report on Tuesday, July 11th. Deutsche Bank AG lifted their target price on Medical Properties Trust from $13.50 to $15.00 and gave the stock a buy rating in a report on Tuesday, July 4th. Royal Bank Of Canada reaffirmed a buy rating and set a $16.00 target price on shares of Medical Properties Trust in a report on Monday, July 24th. Finally, ValuEngine lowered Medical Properties Trust from a buy rating to a hold rating in a report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $14.10.

Shares of Medical Properties Trust (MPW) opened at 13.17 on Tuesday. Medical Properties Trust has a 52 week low of $11.54 and a 52 week high of $15.57. The company has a 50-day moving average of $12.82 and a 200-day moving average of $13.03. The firm has a market capitalization of $4.61 billion, a PE ratio of 16.10 and a beta of 0.88.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.32. The firm had revenue of $166.80 million for the quarter, compared to analyst estimates of $163.08 million. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. Medical Properties Trust’s revenue was up 32.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.32 earnings per share. On average, equities analysts forecast that Medical Properties Trust will post $0.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This report was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://theolympiareport.com/2017/09/02/medical-properties-trust-inc-mpw-rating-reiterated-by-jefferies-group-llc.html.

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, September 14th will be paid a $0.24 dividend. The ex-dividend date is Wednesday, September 13th. This represents a $0.96 dividend on an annualized basis and a yield of 7.29%. Medical Properties Trust’s dividend payout ratio is currently 115.66%.

In related news, CFO R Steven Hamner sold 85,000 shares of Medical Properties Trust stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.00% of the company’s stock.

A number of institutional investors have recently modified their holdings of MPW. Goldman Sachs Group Inc. boosted its position in Medical Properties Trust by 25.2% in the first quarter. Goldman Sachs Group Inc. now owns 1,653,360 shares of the real estate investment trust’s stock valued at $21,311,000 after buying an additional 332,602 shares during the period. Swiss National Bank boosted its position in Medical Properties Trust by 6.2% in the first quarter. Swiss National Bank now owns 527,700 shares of the real estate investment trust’s stock valued at $6,802,000 after buying an additional 30,800 shares during the period. Texas Yale Capital Corp. boosted its position in Medical Properties Trust by 1.9% in the second quarter. Texas Yale Capital Corp. now owns 66,200 shares of the real estate investment trust’s stock valued at $852,000 after buying an additional 1,250 shares during the period. Stratos Wealth Partners LTD. boosted its position in Medical Properties Trust by 13.4% in the first quarter. Stratos Wealth Partners LTD. now owns 26,293 shares of the real estate investment trust’s stock valued at $339,000 after buying an additional 3,112 shares during the period. Finally, RMR Advisors LLC boosted its position in Medical Properties Trust by 5.7% in the second quarter. RMR Advisors LLC now owns 370,320 shares of the real estate investment trust’s stock valued at $4,766,000 after buying an additional 20,000 shares during the period. 85.55% of the stock is currently owned by hedge funds and other institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.